DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $607,920 | -4.9% | 2,533 | -0.2% | 0.49% | -3.9% |
Q1 2023 | $639,425 | +90214.3% | 2,537 | -4.9% | 0.51% | -4.0% |
Q4 2022 | $708 | -99.9% | 2,667 | -7.6% | 0.53% | -8.3% |
Q3 2022 | $746,000 | +1.9% | 2,887 | -0.1% | 0.58% | +15.8% |
Q2 2022 | $732,000 | -13.9% | 2,889 | -0.2% | 0.50% | -2.9% |
Q1 2022 | $850,000 | -11.0% | 2,896 | -0.2% | 0.51% | -11.1% |
Q4 2021 | $955,000 | +8.0% | 2,902 | -0.1% | 0.58% | -2.7% |
Q3 2021 | $884,000 | +13.2% | 2,905 | -0.2% | 0.59% | +11.4% |
Q2 2021 | $781,000 | +18.9% | 2,910 | -0.4% | 0.53% | +6.4% |
Q1 2021 | $657,000 | +0.9% | 2,921 | -0.4% | 0.50% | -10.4% |
Q4 2020 | $651,000 | +2.8% | 2,932 | -0.3% | 0.56% | -7.3% |
Q3 2020 | $633,000 | +18.5% | 2,941 | -2.6% | 0.60% | +4.5% |
Q2 2020 | $534,000 | +23.9% | 3,020 | -3.1% | 0.58% | +6.3% |
Q1 2020 | $431,000 | -11.0% | 3,117 | -1.2% | 0.54% | +13.4% |
Q4 2019 | $484,000 | +6.8% | 3,155 | -1.0% | 0.48% | +10.6% |
Q3 2019 | $453,000 | +1.1% | 3,187 | 0.0% | 0.43% | +3.3% |
Q2 2019 | $448,000 | +3.0% | 3,187 | -3.3% | 0.42% | +0.7% |
Q1 2019 | $435,000 | +15.4% | 3,295 | -3.1% | 0.42% | +13.0% |
Q4 2018 | $377,000 | – | 3,400 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |